# Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis

> **NCT03019029** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Amyloidosis

## Interventions

- **OTHER:** 18-F Florbetapir PET/MR scan

## Key facts

- **NCT ID:** NCT03019029
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-13
- **Primary completion:** 2022-03-24
- **Final completion:** 2022-03-24
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03019029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03019029, "Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03019029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*